Archives

Today R-Biopharm launches the new RIDA®GENE SARS-CoV-2 RUO test for the detection of coronavirus SARS-CoV-2 from human respiratory samples.

On December 31st, 2019, the World Health Organization (WHO) was informed of several cases of severe pneumonia in the Chinese metropolis of Wuhan City, caused by a previously unknown virus.

Dedicated to securing the well-being of both humans and animals, we deliver solutions for the safety and quality of food and animal feed. By offering our team members a trustful work environment [...]

30 years ago, R-Biopharm was founded as a working group with only six employees. Today, it’s a leading developer of test solutions with more than 1,000 employees and subsidiaries and [...]

Sustainable excellence in longterm and profitable growth awarded   After awards in 2010 and 2013, R-Biopharm AG has won the Deloitte Sustained Excellence Award for the third time in a row [...]